Pharma

The San Francisco-based lab will house Eli Lilly experts in biology, science and medicine alongside NVIDIA AI model builders and engineers.

Pharma faces regulations and stringent rules for transparency, but the payoff is drugs that can get to market faster and possibly at less expense.

Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis and Sanofi will sell medicines at a discounted price on TrumpRx.

The collaboration will combine AI and real-world data to accelerate oncology research and drug development.

Amit Gir, CEO of Phox Health, highlights the company's partnerships with UW Medicine, Alaska Airlines and The MetroHealth System to deliver specialty medications in select states, and its plans to expand into drone-based delivery.

PKG Health's movement disorder algorithms and digital endpoints will be integrated into Empatica’s AI-enabled health monitoring wearables.

HRSA is scheduled to issue approvals to drugmakers by Oct. 15 for implementation of the pilot on Jan. 1, 2026.

Thanks to the deal, Pfizer will avoid upcoming U.S. tariffs on overseas-made drugs for three years by offering discounted medications directly to American consumers.

At Healthcare 2030 in Washington, D.C., panelists highlighted debated challenges around interoperability, FHIR adoption and the need for industry-wide standards.

At an event in Washington, D.C., on Monday, DiMe released a thesis with what it says are four impact areas that are vital to pursue in digital medicine in the next five years.